Background and Aims: Macrophage cholesterol efflux is considered a therapeutic target to reduce atherosclerosis susceptibility and induce atherosclerotic lesion regression. 2-hydroxypropyl-β-cyclodextrin (CD) has been suggested to remove cholesterol from cells. In this study, we investigated the effect of CD treatment on macrophage cholesterol efflux in vitro and the ability of established lesions to regress in response to lipid lowering.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Published online: August 03, 2019EAS19-0738
© 2019 Published by Elsevier Inc.